Humana Board Declares Payment of Quarterly Dividend to Stockholders; Increases Per Share Dividend by 12.4 Percent

Humana Inc. (NYSE: HUM) has declared a cash dividend of $0.885 per share, an increase of 12.4% from the previous $0.7875.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

LOUISVILLE, Ky.--(BUSINESS WIRE)-- Humana Inc. (NYSE: HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on April 28, 2023 to stockholders of record as of the close of business on March 31, 2023. The dividend of $0.885 per share reflects an increase of 12.4 percent from the previous per share dividend of $0.7875.

About Humana

Humana Inc. (NYSE: HUM) is committed to helping our millions of medical and specialty members achieve their best health. Our successful history in care delivery and health plan administration is helping us create a new kind of integrated care with the power to improve health and well-being and lower costs. Our efforts are leading to a better quality of life for people with Medicare, families, individuals, military service personnel, and communities at large.

To accomplish that, we support physicians and other health care professionals as they work to deliver the right care in the right place for their patients, our members. Our range of clinical capabilities, resources and tools – such as in-home care, behavioral health, pharmacy services, data analytics and wellness solutions – combine to produce a simplified experience that makes health care easier to navigate and more effective.

More information regarding Humana is available to investors via the Investor Relations page of the company’s website at humana.com, including copies of:

• Annual reports to stockholders
• Securities and Exchange Commission filings
• Most recent investor conference presentations
• Quarterly earnings news releases and conference calls
• Calendar of events
• Corporate Governance information

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20230216005284/en/

Lisa Stoner
Humana Investor Relations
(502) 580-2652
e-mail: lstamper@humana.com

Mark Taylor
Humana Corporate Communications
(317) 753-0345
e-mail: Mtaylor108@humana.com

Source: Humana Inc.